The Online Investor
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
Medical Instruments & Supplies M&A image Medical Instruments & Supplies M&A » By The Online Investor Staff, updated Tue., Apr. 30, 10:55 AM Recent mergers and acquisitions in the Medical Instruments & Supplies M&A category.

Slide #26. Fluidigm DVS Sciences

Acquirer: Fluidigm (FLDM)
Acquiree: DVS Sciences
Details: Fluidigm Corp. (NASDAQ:FLDM) today announced it has completed its acquisition of DVS Sciences, Inc. With the closing of the acquisition, Fluidigm adds a high-parameter single-cell protein analysis platform to its industry-leading single-cell genomics platforms to create a comprehensive portfolio of advanced technologies serving the rapidly growing single-cell genomics and proteomics markets.

Fluidigm creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents and software that are used by researchers and clinical labs worldwide. Co. markets technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, polymerase chain reaction, Library Preparation, Single Cell Genomics, and consumables, including integrated fluidic circuits, assays, and reagents. Co.'s product offerings include: Mass Cytometry, Microfluidics and Single Cell Microfluidics.

Open the FLDM Page at The Online Investor »

Company Name:  Standard BioTools Inc
Website:  www.fluidigm.com
Sector:  Medical Instruments & Supplies
 

Open the FLDM Page at The Online Investor (in a new window) »

April 30, 2024    10:55 AM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree FLDM Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
FLDM Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Medical Instruments & Supplies M&A - Slide 26 of 100 | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.